Cannabis firm mulls London listing
An Israeli cannabis firm has set its sights on London’s main stock exchange. Kanabo Research says it wants to beat its rivals to become the first cannabis company to list on the London Stock Exchange, a market it says has better prospects despite regulatory hurdles and the uncertainty surrounding Brexit. Cannabis companies have listed in Israel and Canada — where the relaxation of laws led to legalisation last year — while GW Pharmaceuticals, which develops marijuana-based epilepsy treatments, has previously listed on London’s Alternative Investment Market.